UpHealth (UPHL) Competitors

$0.84
+0.09 (+12.00%)
(As of 05/13/2024 ET)

UPHL vs. ATPC, PEAR, EUDA, TLIS, TTOO, NRSN, TRAW, COCP, QTI, and APM

Should you be buying UpHealth stock or one of its competitors? The main competitors of UpHealth include Agape ATP (ATPC), Pear Therapeutics (PEAR), EUDA Health (EUDA), Talis Biomedical (TLIS), T2 Biosystems (TTOO), NeuroSense Therapeutics (NRSN), Traws Pharma (TRAW), Cocrystal Pharma (COCP), QT Imaging (QTI), and Aptorum Group (APM). These companies are all part of the "medical" sector.

UpHealth vs.

UpHealth (NYSE:UPHL) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership, community ranking and earnings.

In the previous week, Agape ATP had 4 more articles in the media than UpHealth. MarketBeat recorded 4 mentions for Agape ATP and 0 mentions for UpHealth. Agape ATP's average media sentiment score of 0.69 beat UpHealth's score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media.

Company Overall Sentiment
UpHealth Neutral
Agape ATP Positive

56.1% of UpHealth shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Agape ATP has lower revenue, but higher earnings than UpHealth. Agape ATP is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.12-$56.42M-$3.22-0.26
Agape ATP$1.43M12.83-$2.10M-$0.02-11.92

UpHealth has a net margin of -44.49% compared to Agape ATP's net margin of -147.31%. UpHealth's return on equity of 36.86% beat Agape ATP's return on equity.

Company Net Margins Return on Equity Return on Assets
UpHealth-44.49% 36.86% 10.32%
Agape ATP -147.31%-125.96%-73.44%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UpHealth
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Agape ATP
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

UpHealth and Agape ATP both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
UpHealthN/AN/A
Agape ATPN/AN/A

Summary

UpHealth beats Agape ATP on 7 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPHL vs. The Competition

MetricUpHealthHealth services IndustryMedical SectorNYSE Exchange
Market Cap$15.80M$856.28M$4.97B$17.83B
Dividend YieldN/A1.65%39.25%3.47%
P/E Ratio-0.2623.01153.9424.58
Price / Sales0.122.452,362.5510.55
Price / Cash0.1319.6832.8015.76
Price / Book0.272.324.965.08
Net Income-$56.42M-$15.00M$103.30M$964.97M
7 Day Performance-4.55%1.19%-0.57%0.73%
1 Month Performance-16.83%12.23%-0.95%2.84%
1 Year PerformanceN/A25.72%5.05%131.45%

UpHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATPC
Agape ATP
0 of 5 stars
$0.24
flat
N/AN/A$18.13M$1.43M-11.7821Upcoming Earnings
Short Interest ↑
PEAR
Pear Therapeutics
0 of 5 stars
N/AN/AN/A$4.17M$12.69M-0.13300
EUDA
EUDA Health
0 of 5 stars
$1.97
+12.6%
N/A+65.7%$48.52M$7.55M0.00150Short Interest ↓
TLIS
Talis Biomedical
0.2713 of 5 stars
$9.21
-1.0%
$5.00
-45.7%
+36.1%$16.76M$2.13M-0.2799
TTOO
T2 Biosystems
0.1859 of 5 stars
$3.05
-5.9%
$3.00
-1.6%
-86.9%$16.81M$7.19M0.00113Short Interest ↑
NRSN
NeuroSense Therapeutics
0 of 5 stars
$1.23
-4.7%
N/A-31.0%$16.81MN/A-1.4818Short Interest ↓
TRAW
Traws Pharma
0 of 5 stars
$0.65
-1.5%
N/AN/A$16.46M$230,000.00-0.7117Upcoming Earnings
Gap Up
COCP
Cocrystal Pharma
2.8982 of 5 stars
$1.61
+1.9%
$10.00
+523.1%
-34.7%$16.32MN/A-0.8112Upcoming Earnings
Short Interest ↑
News Coverage
Gap Up
QTI
QT Imaging
0 of 5 stars
$0.80
+1.0%
N/AN/A$17.10MN/A0.00N/AGap Up
High Trading Volume
APM
Aptorum Group
0 of 5 stars
$4.50
-12.8%
N/A+45.5%$16.07M$430,000.000.0018Short Interest ↓
Positive News

Related Companies and Tools

This page (NYSE:UPHL) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners